Often begin imperceptibly: recurrent headaches, insomnia, chronic fatigue. These seemingly harmless symptoms may indicate many serious neurological and mental diseases, such as Alzheimer’s disease, alcoholism, depression, etc. And in many people, the tendency to these conditions is due to heredity.
Genetic predisposition to various diseases does not mean that the disease cannot be stopped. Knowing your genetic characteristics, you can significantly reduce the risks of developing dangerous diseases, and if they are detected, you can choose a personalized therapy that will be effective and will not cause complications.
Molecular genetic testing is used to confirm a clinical diagnosis, as well as a preventive diagnosis for people with a burdened anamnesis. Genetic research is indicated for people whose relatives suffer from neurological or mental diseases, as well as for couples at the stage of pregnancy planning.
Neurological diseases
Sistema BioTech offers the following genetic studies:
Genetic Predisposition to Psychic Trauma (COMT, FKBP5, HTR1A)
The genetic predisposition to psychological trauma and the severity of its experience is often associated with the metabolism of neurotransmitters, such as serotonin, dopamine and their precursors. The current panel will help identify the presence of mutations in the genes encoding both the neurotransmitters themselves, for example, serotonin (the mood hormone), and the enzymes involved in the metabolism of neurotransmitters.
Depression is a whole complex of mental disorders, the main manifestation of which is a long-term decrease in mood and performance. It has been scientifically proven that the disease is caused by a violation of the synthesis and distribution of neurotransmitters in the brain. Some forms of depression run in families and are hereditary. The disease is caused by a violation of the synthesis and distribution of neurotransmitters in the brain.
Genetic predisposition to early development of Alzheimer’s disease (APOE, HFE, APP, PSEN1)
Alzheimer’s disease is a neurodegenerative disease characterized by progressive dementia, loss of cognition and deterioration in quality of life. Early onset occurs at the age of30 and accounts for less than 10% of all the people with Alzheimer’s disease. Often the disease is hereditary and is caused by gene mutations.
Genetic research from Sistema BioTech will help you find out if you have gene variants associated with an increased risk of developing Alzheimer’s disease.
Genetic predisposition to developing Parkinson’s disease (DRD1, DRD2, ADH1C, PARK7)
Parkinson’s disease is a neurodegenerative disease of the brain associated with the destruction of the structures responsible for the production of dopamine. Approximately 20% of patients have a hereditary form of the disease. Genetic mutations provoke the destruction of the cells of the substantia nigra of the brain. Genetic study from Sistema BioTech aims to identify the genetic predisposition to the development of Parkinson’s disease
Genetically determined predisposition to alcoholism (COMT, ALDH2)
A serious factor in the development of alcoholism is heredity. The presence of certain changes in the genes increases the likelihood of developing alcohol dependence. The use of molecular genetic methods aimed at identifying and assessing genetic risk will clarify the treatment regimen and the need for preventive measures, such as lifestyle changes.
To place an order for a test system, fill out the form. Orders are accepted for legal entities and individuals.
Заполните форму для получения информации о продукте, индивидуальной демонстрации или ценового предложения.
To place an order, please fill out the form
Place an order
We use cookies!
Sistema Biotech uses cookies to improve the quality of the website. By clicking "OK" in the corresponding field of this message, you confirm that you have provided Sistema Biotech with your consent to the use of your cookies.
We use cookies!
Cookie Settings
Cookies are used to provide a simple and efficient service to the users, browsing the pages